Maxim Group

Unusual Machines Revenue Could Double In 2025 Under Trump Administration, Says Analyst

cbdMD Secures $2.8M Via Underwritten Public Offering Of Common Stock

New Cannabis IPOs – Clover Leaf Prices $125M, Silver Spike Prices $150M

cbdMD Secures $2.8M Via Underwritten Public Offering Of Common Stock

New Cannabis IPOs – Clover Leaf Prices $125M, Silver Spike Prices $150M

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More

Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals

Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More

Small-Cap Biotech Execs On Latest Advancements, Post-Pandemic Return To Fundamentals

Maxim Group Is Bullish About Biotricity Generating Over 100% Revenue Growth

3 Penny Stocks To Buy According To Top Stock Market Analysts

Maxim Group Recent News

Maxim Group Upgrades Titan Pharma As 'ProNeura Pivots To Pruritus'

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is set to begin a new phase, according to Maxim Group, after undergoing several changes in strategy, management, capital structure and financing through 2020 and into 2021.

New Bear Takes A Bite Out Of Apple: Maxim Downgrades Stock To Sell

What's Behind TrovaGene's Volatile Ride?

Maxim Group Says Chipotle Has 'Enviable Position' Among Restaurant Stocks

Maxim Has An Appetite For Potbelly

A Dunkin' By Any Other Name: Maxim Raises Stock's Price Target

Maxim Projects Nearly 200% Upside Potential For Overstock, Names Blockchain, Retail As Drivers

Maxim: Habit Restaurants No Longer A Buy, Consider Del Taco Instead

Cracker Barrel Is Undervalued, Maxim Says In Upgrade

After 44% Run, Domino's Pizza Hit With A Downgrade On Valuation

Maxim Explains Viking Therapeutics' Sympathy Move With Madrigal

HP's Q2 Print, 3-D Printing Business Trigger Maxim Upgrade

Maxim Group: Apple's Long-Term Services Business 'Not Attractive Enough' For Bullish Rating

Zoe's Kitchen's Downgraded By Maxim After Tough Q1; Growth Story 'Broken For Now'

Omeros Elevated By Medicare Reimbursement And OMS721 Progress, Says Maxim

Aramchol's Failed Past Isn't Its Future; Galmed Gets An Upgrade

A Look At What MoviePass Has Accomplished In 6 Months

Analyst Confident In Helios And Matheson Thanks To MoviePass

Dunkin' Brands Is 2018's First Go-Private Rumor; Shares Benefit

Maxim Highlights Manhattan Bridge Capital, A Niche REIT With A Rising Dividend

Can NXT-ID's Crypto Platform Lead More Merchants To Accept Digital Currency? Maxim Weighs In

NXT-ID Rallies After Announcing Cryptocurrency Retail Payment Platform

Analyst: As The Food Sector Consolidates, Hain Celestial Could Be Attractive M&A Target